(Q35621701)

9 August 2017

1 reference

title

Combination therapy for chronic hepatitis B. (English)

1 reference

9 August 2017

1 reference

Solko W Schalm

1

1 reference

9 August 2017

publication date

1 January 2003

1 reference

9 August 2017

published in

Journal of Hepatology

1 reference

9 August 2017

volume

39 Suppl 1

1 reference

9 August 2017

page(s)

S146-50

1 reference

Lamivudine and alpha interferon combination treatment of patients with chronic hepatitis B infection: a randomised trial

9 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900352-0

7 January 2021

Long-term efficacy of interferon alpha-2b and lamivudine in combination compared to lamivudine monotherapy in patients with chronic hepatitis B. An Italian multicenter, randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900352-0

7 January 2021

Lamivudine and 24 weeks of lamivudine/interferon combination therapy for hepatitis B e antigen-positive chronic hepatitis B in interferon nonresponders.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900352-0

7 January 2021

Lamivudine/interferon combination therapy in anti-HBe positive chronic hepatitis B patients: a controlled pilot study

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900352-0

7 January 2021

Lamivudine and alpha-interferon in combination long term for precore mutant chronic hepatitis B.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900352-0

7 January 2021

Safety and efficacy of adefovir dipivoxil in patients co-infected with HIV-1 and lamivudine-resistant hepatitis B virus: an open-label pilot study

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900352-0

7 January 2021

Sequential treatment with lamivudine and interferon monotherapies in patients with chronic hepatitis B not responding to interferon alone: results of a pilot study

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900352-0

7 January 2021

Clinical and immunological efficacy of intradermal vaccine plus lamivudine with or without interleukin-2 in patients with chronic hepatitis B.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900352-0

7 January 2021

10.1016/S0168-8278(03)00352-0

Identifiers

DOI

1 reference

9 August 2017

1 reference